|Articles|May 15, 2020

ASCRS 2020: TearClear CEO shares company's vision, mission for future

Ophthalmology Times'  Sheryl Stevenson speaks with Robert Dempsey, TearClear's new CEO, on his goals for the company, its mission and vision in the future of the coronavirus, as well as what to keep an eye out for at the 2020 ASCRS virtual meeting.

 

See more ASCRS conference coverage here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME